Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (384)
- Scheduling (national classification system) (181)
- Safety monitoring and information (33)
- COVID-19 (11)
- Manufacturing (10)
- Advertising (9)
- Clinical trials (9)
- Compliance and enforcement (6)
- Medicinal cannabis hub (6)
- Sunscreens (6)
- Fees and payments (5)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
784 result(s) found, displaying 776 to 784
-
Corporate reportsA review of the regulation of head lice preparations in Australia
-
Meeting statementsSummary to provide advice of the Resolutions made by the Therapeutic Goods Committee at its 24th Meeting held on 4 May 2004
-
Meeting statementsSummary to provide advice of the Resolution made by the Therapeutic Goods Committee (TGC) out-of-session during February 2004
-
Meeting statementsSummary to provide advice of the Resolutions made by the Therapeutic Goods Committee at its 23rd Meeting held on 17 December 2003
-
Meeting statementsSummary to provide advice of the Resolutions made by the Therapeutic Goods Committee at its 22nd Meeting held on 11 August 2003
-
Meeting statementsSummary to provide advice of the Resolutions made by the Therapeutic Goods Committee at its 21st Meeting held on 11 February 2003
-
Meeting statementsSummary to provide advice of the Resolutions made by the Therapeutic Goods Committee at its 20th Meeting held on 16 April 2002
-
Meeting statementsSummary to provide advice of the Resolutions made by the Therapeutic Goods Committee at its 19th Meeting held on 8 November 2001
-
Corporate reportsThe IRIS is responsible for the management of all reports of adverse events or problems associated with medical devices that are reported to the TGA.